Improving outcomes in relapsed/refractory Non Hodgkin lymphoma (NHL)
News
Biospecific antibodies are showing promising activity in early phase trials in relapsed/refractory Non-Hodgkin lymphoma (NHL), including patients that have received prior CAR-T therapies.
The ACCEPT and ProCAID trials
News
Read about the ACCEPT (a phase Ib/II) and ProCAID (placebo controlled randomised phase II) trials taking place at Southampton ECMC
Updates from the Advanced and Cell Therapies and Haematology teams within Manchester ECMC
News
Read recent updates from the Advanced & Cell Therapies team led by Professor Fiona Thistlethwaite and about the recent appointment of Dr Emma Searle to the Haematology team within the Manchester ECMC
Network Intelligence Framework
Basic page
Immunohistochemistry Workshop (Mar21)
Event
The Institute of Cancer Research and the ECMC jointly present an Immunohistochemistry (IHC) workshop on emerging technologies and application of IHC in clinical research. The workshop is aimed to support researchers, clinicians working on IHC and PhD students. The workshop is taking place via Zoom on 26 March 2021, 9am-12pm.
Spotlight Interview - introducing new ECMC team members
News
The ECMC Programme Office has welcomed two new members to the team over the past few months: Catherine Cowell (Research Manager) and Lauren Griffiths (Early Phase Clinical Trials Business Development Manager). Learn more about them and the work they do as part of the team. Catherine Cowell What is your...
ECMC Quinquennial Review 12-month delay
News
ECMC Quinquennial Review 12-month delay The ECMC Network quinquennial review process has been delayed for 12-months, due to the impact of the pandemic on the ECMC Network sites. The current 5- year ECMC funding period (2017 – 2022) is due to end in March 2022. A quinquennial review process was...
Remote monitoring guidance
News
At the beginning of 2020, the COVID-19 Pandemic resulted in restrictions which made on-site monitoring of clinical trial data and documents more challenging due to safety and social distancing restrictions. These restrictions meant alternative ways of monitoring clinical trials needed to be explored and implemented to ensure data integrity and...
Spotlight interview - Bob Brown, Imperial ECMC
News
As Professor Bob Brown prepares to retire we caught up with him as he reflected on his career and his involvement in the ECMC network.
Spotlight Interview - Fiona Thomson, Glasgow ECMC
News
Dr Fiona Thomson is leaving Glasgow ECMC for a new role with AstraZenca. Here Fiona shares her thoughts on the ECMC network and working in both industry and academic.